US2007155668A1PendingUtilityA1

Peptides modulating the activity of the engrailed transcription factor

Assignee: UNIV PARIS 13 NORDPriority: May 20, 2003Filed: May 19, 2004Published: Jul 5, 2007
Est. expiryMay 20, 2023(expired)· nominal 20-yr term from priority
A61P 43/00A61P 25/00A61P 25/16A61P 25/30C07K 7/08C07K 19/00C07K 2319/00A61K 38/00
40
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention relates to peptides which can become fixed to the engrailed transcription factor and which can modulate the activity thereof.

Claims

exact text as granted — not AI-modified
1 . A peptide capable of binding to the Engrailed transcription factor, chosen from: 
 the peptide of sequence SWWETQLIASSG;    the peptide of sequence WSWNEEVWFPFT.    
     
     
         2 . A composition comprising a peptide as claimed in  claim 1 , combined with a peptide comprising a transducing domain.  
     
     
         3 . The composition as claimed in  claim 2 , characterized in that said transducing peptide is a penetratin.  
     
     
         4 . The composition as claimed in  claim 3 , characterized in that said transducing peptide is the Engrailed protein, or a fragment thereof comprising at least its homeodomain.  
     
     
         5 . The composition as claimed in any one of claims  2  to 4, characterized in that it consists of a chimeric polypeptide.  
     
     
         6 . A polynucleotide chosen from: 
 a polynucleotide encoding a peptide as claimed in  claim 1;     a polynucleotide encoding a chimeric polypeptide as defined in  claim 5 .    
     
     
         7 . The use of a peptide as claimed in  claim 1 , of a composition as claimed in any one of  claims 2  to  5 , or of a polynucleotide as claimed in  claim 6 , for regulating, in vitro, the activity of the Engrailed transcription factor in a living cell.  
     
     
         8 . The use of a peptide as claimed in  claim 1 , of a composition as claimed in any one of  claims 2  to  5 , or of a polynucleotide as claimed in  claim 6 , for obtaining a medicinal product.

Join the waitlist — get patent alerts

Track US2007155668A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.